| Bioactivity | Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells[1]. | ||||||
| Name | Cyclosomatostatin | ||||||
| CAS | 84211-54-1 | ||||||
| Shortening | Cyclo(KT-{Oaa}-FW) | ||||||
| Formula | C44H57N7O6 | ||||||
| Molar Mass | 779.97 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Cyclosomatostatin
CAS: 84211-54-1 F: C44H57N7O6 W: 779.97
Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin can inhibit somatostatin recepto
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.